In the MASLD group, the risk factors for ALT levels >30 U/L, as determined by univariate analysis, were male sex, younger age, and the following cardiovascular metabolic risk factors: obesity/central obesity, high triglycerides, and reduced HDL cholesterol. This evidence concerns the gene GPT and obesity disorder.